1. EP-1457: GemOx with low-dose RT and SBRT for locally advanced pancreatic cancer: preliminary safety results. (April 2018) Authors: Meduri, B.; Aluisio, G.; D'Angelo, E.; Tata, C.; Gelsomino, F.; Spallanzani, A.; Ballarin, R.; De Marco, G.; Luppi, G.; Di Benedetto, F.; Cascinu, S.; Lohr, F. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. H10Mutational analysis of EGFR, c-KIT, PDGFRs, BRAF and KRAS, and expression of ALK and PD-L1 in a series of 103 thymic epithelial tumors with different histology. (26th September 2015) Authors: Longo, L.; Barbieri, F.; Bertolini, F.; Tiseo, M.; Migaldi, M.; Giardina, D.; Montanari, G.; Vincenzi, G.; Tomasello, C.; Noventa, S.; Spallanzani, A.; Sighinolfi, P.; Sartori, G.; Bordi, P.; Rossi, G. Journal: Annals of oncology Issue: Volume 26(2015)Supplement 6 Page Start: vi Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-1047: GemOx with low-dose RT and SBRT for locally advanced pancreatic cancer: a prospective trial. (November 2020) Authors: Meduri, B.; Aluisio, G.; D'Angelo, E.; Vernaleone, M.; Tata, C.; Gelsomino, F.; Spallanzani, A.; Ballarin, R.; Luppi, G.; Di Benedetto, F.; Lohr, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗